NEW YORK – Analyzing circulating tumor DNA can both speed up and boost the enrollment of cancer patients into clinical trials, according to a new study focusing on gastrointestinal cancer.
NEW YORK – Analyzing circulating tumor DNA can both speed up and boost the enrollment of cancer patients into clinical trials, according to a new study focusing on gastrointestinal cancer.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.